Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Aktionär | Typ | Gehalten (Tatsächlich) | % Ausstehender Aktien | Marktwert | Positionsdatum |
|---|---|---|---|---|---|
| FMR LLC | Institution | 4.303.156 | 12,74% | 234,52M € | 2026-03-31 |
| BVF Partners L.P. | Institution | 2.559.595 | 7,58% | 139,50M € | 2026-03-31 |
| Two Seas Capital LP | Institution | 1.959.178 | 5,80% | 106,78M € | 2026-03-31 |
| Two Seas Global (Master) Fund Lp | Institution | 1.959.178 | 5,80% | 106,78M € | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 1.365.482 | 4,04% | 74,42M € | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 1.197.055 | 3,54% | 65,24M € | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 997.300 | 2,95% | 54,35M € | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 930.741 | 2,75% | 50,73M € | 2026-03-31 |
| Prosight Management, LP | Institution | 735.000 | 2,18% | 40,06M € | 2026-03-31 |
| BlackRock, Inc. | Institution | 692.650 | 2,05% | 37,75M € | 2026-03-31 |
| Emerald Advisers, LLC | Institution | 650.710 | 1,93% | 35,46M € | 2026-03-31 |
| Morgan Stanley | Institution | 637.935 | 1,89% | 34,77M € | 2026-03-31 |
| Armistice Capital LLC | Institution | 578.000 | 1,71% | 31,50M € | 2026-03-31 |
| Citadel Advisors LLC | Institution | 513.531 | 1,52% | 27,99M € | 2026-03-31 |
| Sofinnova Investments, Inc. | Institution | 509.546 | 1,51% | 27,77M € | 2026-03-31 |
| Invesco Ltd. | Institution | 425.341 | 1,26% | 23,18M € | 2026-03-31 |
| Woodline Partners LP | Institution | 415.335 | 1,23% | 22,64M € | 2026-03-31 |
| Lord, Abbett & Co. LLC | Institution | 405.080 | 1,20% | 22,08M € | 2026-03-31 |
| Millennium Management LLC | Institution | 404.277 | 1,20% | 22,03M € | 2026-03-31 |
| Qube Research & Technologies Ltd | Institution | 390.675 | 1,16% | 21,29M € | 2026-03-31 |
| UBS Asset Management AG | Institution | 354.197 | 1,05% | 19,30M € | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 346.795 | 1,03% | 18,90M € | 2026-03-31 |
| Integrated Core Strategies (US) LLC | Institution | 333.576 | 0,99% | 18,18M € | 2025-09-30 |
| Great Point Partners, LLC | Institution | 316.453 | 0,94% | 17,25M € | 2026-03-31 |
| Vestal Point Capital, LP | Institution | 285.000 | 0,84% | 15,53M € | 2026-03-31 |
| Susquehanna International Group, LLP | Institution | 283.617 | 0,84% | 15,46M € | 2026-03-31 |
| 22NW, LP | Institution | 281.115 | 0,83% | 15,32M € | 2026-03-31 |
| PRIMECAP Management Company | Institution | 279.150 | 0,83% | 15,21M € | 2026-03-31 |
| OrbiMed Advisors LLC | Institution | 275.000 | 0,81% | 14,99M € | 2026-03-31 |
| Gilder Gagnon Howe & Co. LLC | Institution | 271.758 | 0,80% | 14,81M € | 2026-03-31 |
| Nearwater Capital Markets, Limited | Institution | 261.500 | 0,77% | 14,25M € | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 244.727 | 0,72% | 13,34M € | 2026-03-31 |
| JPMorgan Chase & Co. | Institution | 240.101 | 0,71% | 13,09M € | 2026-03-31 |
| Braidwell LP | Institution | 222.701 | 0,66% | 12,14M € | 2026-03-31 |
| Patient Square Capital, LP | Institution | 210.000 | 0,62% | 11,45M € | 2026-03-31 |
| Bronte Capital Management Pty Ltd | Institution | 198.256 | 0,59% | 10,80M € | 2026-03-31 |
| Quinn Opportunity Partners LLC | Institution | 179.247 | 0,53% | 9,77M € | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 169.308 | 0,50% | 9,23M € | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | Institution | 168.007 | 0,50% | 9,16M € | 2026-03-31 |
| Dafna Capital Management, LLC | Institution | 165.178 | 0,49% | 9,00M € | 2026-03-31 |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
